Infectious Bacterial Diseases Research Unit Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Research Project: PREVENTION AND CONTROL STRATEGIES FOR TUBERCULOSIS IN CATTLE AND WILDLIFE RESERVOIRS

Location: Infectious Bacterial Diseases Research Unit

Title: Evaluation of gamma interferon (IFN-gamma)-induced protein 10 (IP-10) responses for detection of cattle infected with Mycobacterium bovis: comparisons to IFN-gamma responses

Authors
item Waters, Wade
item Thacker, Tyler
item Nonnecke, Brian
item Palmer, Mitchell
item Schiller, I -
item Oesch, B -
item Vordermeier, H -
item Silva, E -
item Estes, D -

Submitted to: Clinical and Vaccine Immunology
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: December 29, 2011
Publication Date: March 1, 2012
Citation: Waters, W.R., Thacker, T.C., Nonnecke, B.J., Palmer, M.V., Schiller, I., Oesch, B., Vordermeier, H.M., Silva, E., Estes, D.M. 2012. Evaluation of gamma interferon (IFN-gamma)-induced protein 10 responses for detection of cattle infected with Mycobacterium bovis: comparisons to IFN-gamma responses. Clinical and Vaccine Immunology. 19(3):346-351.

Interpretive Summary: Bovine tuberculosis (TB), caused by Mycobacterium bovis, has an important and adverse effect on socioeconomic, public health and trade of animals and animal products. The eradication of bovine TB in cattle is based on the detection and slaughter of infected animals or whole herds. Additional tools are needed to better diagnose TB in cattle. In the present study, a novel test for the detection of TB in cattle was evaluated. Knowledge obtained from this study may lead to an improved test for tuberculosis, thereby, advancing the national tuberculosis eradication program.

Technical Abstract: Gamma interferon (IFN-gamma)-induced protein 10 (IP-10) has recently shown promise as a diagnostic biomarker of Mycobacterium tuberculosis infection of humans. The aim of the current study was to compare IP-10 and IFN-gamma responses upon Mycobacterium bovis infection in cattle using archived samples from two aerosol inoculation studies. In the first study (10**4 cfu M. bovis, n = 7), M. bovis purified protein derivative (PPDb)-specific IP-10 and IFN-gamma gene expression were detected as early as 29d after challenge. PPDb-specific IP-10 and IFN-gamma mRNA responses followed a similar pattern of expression over the course of this study and were highly correlated (r = 0.852). In the second study (10**5 cfu M. bovis, n = 5), IP-10 and IFN-gamma (protein) responses to mycobacterial antigens were compared following challenge. IFN-gamma responses to mycobacterial antigens were detected 29d after challenge and were sustained during the remainder of the study. IFN-gamma responses to mycobacterial antigens exceeded corresponding responses in non-stimulated cultures. IP-10 responses to mycobacterial antigens exceeded pre-infection responses at 7d, 29d and 63d after challenge. In contrast to IFN-gamma, IP-10 responses to mycobacterial antigens generally did not exceed respective responses in non-stimulated cultures. IP-10 responses to media alone and to mycobacterial antigens followed a similar pattern of response. Correlations between IP-10 and IFN-gamma (protein) responses were modest (r ˜ 0.50 – 0.65). Taken together, these findings do not support the use of IP-10 protein as a biomarker for bovine TB using the current testing protocol and reagents; however, mRNA-based assays may be considered for further analysis.

   

 
Project Team
Waters, Wade
Palmer, Mitchell
Thacker, Tyler
 
Publications
   Publications
 
Related National Programs
  Animal Health (103)
 
Related Projects
   ACTIVATION OF GAMMA DELTA T CELLS IN RESPONSE TO IMPORTANT BACTERIAL PATHOGENS
 
 
Last Modified: 05/21/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House